Oral microbiome in HIV-associated periodontitis by Noguera-Julian, Marc et al.
Observational Study Medicine®
OPENMarc Noguera-Julian, PhDa,b,c,
∗
, Yolanda Guillén, PhDa,Oral microbiome in HIV-associated periodontitis
b, Jessica Peterson, BsCd, David Reznik, DDSd,e,
Erica V. Harris, BsCf, Sandeep J. Joseph, PhDd, Javier Rivera, MsCa,c, Sunil Kannanganat, PhDd,g,
Rama Amara, PhDd,g, Minh Ly Nguyen, MDd, Simon Mutembo, MDh, Roger Paredes, MD, PhDa,b,c,i,
Timothy D. Read, PhDd, Vincent C. Marconi, MDd,g,
∗
Abstract
HIV-associated periodontal diseases (PD) could serve as a source of chronic inﬂammation. Here, we sought to characterize the oral
microbial signatures of HIV+ and HIV– individuals at different levels of PD severity.
This cross-sectional study included both HIV+ and HIV– patients with varying degrees of PD. Two tooth, 2 cheek, and 1 saliva
samples were obtained for microbiome analysis. Mothur/SILVADB were used to classify sequences. R/Bioconductor (Vegan,
PhyloSeq, and DESeq2) was employed to assess overall microbiome structure differences and differential abundance of bacterial
genera between groups. Polychromatic ﬂow cytometry was used to assess immune activation in CD4 and CD8 cell populations.
Around 250 cheek, tooth, and saliva samples from 50 participants (40 HIV+ and 10 HIV–) were included. Severity of PD was
classiﬁed clinically as None/Mild (N), Moderate (M), and Severe (S) with 18 (36%), 16 (32%), and 16 (32%) participants in each
category, respectively. Globally, ordination analysis demonstrated clustering by anatomic site (R2=0.25, P<0.001). HIV status and
PD severity showed a statistically signiﬁcant impact on microbiome composition but only accounted for a combined 2% of variation.
HIV+ samples were enriched in genera Abiotrophia, Neisseria, Kingella, and unclassiﬁed Neisseriaceae and depleted in Leptotrichia
and Selenomonas. The Neisseria genus was consistently enriched in HIV+ participants regardless of sampling site and PD level.
Immune markers were altered in HIV+ participants but did not show association with the oral microbiome.
HIV-associated changes in oral microbiome result in subtle microbial signatures along different stages of PD that are common in
independent oral anatomic sites.
Abbreviations: HIV = human immunodeﬁciency virus, CDC/AAP = Centers for Disease Control/American Academy of
Periodontology, KEGG = Kyoto Encyclopedia of Genes and Genomes, LEFSE = LDA effect size, PCoA = principal coordinates
analysis, PICRUSt = Phylogenetic Investigation of Communities by Reconstruction of Unobserved States, PD = periodontal disease,
HAART = highly active antiretroviral therapy, VL = viral load.
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Periodontal disease (PD) includes a number of inﬂammatory-
based conditions such as gingivitis and periodontitis, which are
the most common infectious diseases affecting tooth-supporting
bone structures. Untreated periodontitis affects more than 700
million people worldwide,[1] can lead to tooth loss, and has been
linked to conditions such as cardiovascular disease, diabetes
mellitus, or obesity.[1]
Over the last 30 years, severe PD has been associated with HIV
infection.[2] Although antiretroviral therapy (ART) preserves and
restores immune function and prevents the development of
opportunistic infections, individuals with sustained virological
suppression continue to experience an increased incidence of age-
related comorbidities (including PD) with synergistic effects on
survival and quality of life. The determinants, course, and impact
on other comorbid conditions of severe PD in the setting of ART
remain a matter of controversy.[3,4]
In classical microbiology descriptions, increases in Porphyor-
monas gingivalis, Treponema denticola, and Tannerella forsyth-
ia, the so-called red complex, were strongly associated with
destructive PD, whereas predominance of other bacterial
complexes was associated to less severe PD.[5–8] The formation
of plaque in mature teeth with an enriched proportion of Gram-
negative anaerobic bacteria activates pro-inﬂammatory path-
ways and promotes the formation of periodontal pockets. These
pockets allow for the local accumulation of anaerobic bacteria,
against which the host response is inefﬁcient and even counter-
productive. With the arrival of new sequencing technologies,
periodontitis has been linked to a broader disbyosis in the oral
microbiome, initiated by changes in key pathogenic species with a
context of accessory pathogens and their expression proﬁles.
These changes promote a proinﬂammatory community and can
trigger tissue destruction augmented by the host immune
response.[9–16]
To date, research on the interplay between HIV infection, the
oral microbiome, and PD has produced inconclusive results. A
small study in children with only 5 HIV-negative controls found
no evident differences in the oral microbiome composition
between well-controlled HIV-positive and HIV-negative chil-
dren.[17] In comparison, 15 subjects with AIDS attending HIV
clinics in China showed signiﬁcant increases in several bacteria,
and a distinct salivary bacterial proﬁle between necrotic and
chronic PD.[18] Using a microbial microarray, there were
signiﬁcant differences in the salivary bacterial composition
between HIV-positive subjects before and after ART initiation
and between them and HIV-negative adults.[19] Moreover, an
independent study revealed increased diversity in subgingival
bioﬁlms of HIV+ individuals within a Brazilian cohort of 32
subjects with PD.[20]
Here, we sought to characterize how HIV infection and other
related factors modulate oral microbiome communities in
different PD states using high throughput technologies and also
identify speciﬁc oral microbiome markers of HIV infection.2. Methods
2.1. Study design
This was a cross-sectional study including both HIV+ and HIV–
participants with varying degrees of PD. HIV+ patients were
recruited in the Oral Health Center of Infectious Disease Program
at Grady Memorial Hospital located in Atlanta, GA. HIV-1
infection was documented by ELISA and conﬁrmed by Western2blot at any time prior to study entry. HIV– control samples
were obtained from clinical and research staff at the same
institution. HIV– participants were required to demonstrate
HIV seronegativity in the prior 30 days before inclusion in the
study byHIV free testing at the Infectious Disease Program Ponce
Clinic.
PDwas assessed by the oral exam using the Centers for Disease
Control/merican Academy of Periodontology (CDC/AAP) crite-
ria based on the tooth clinical attachment level (CAL) and the
probing pocket depth (PPD):[21](1) Severe PD (S-PD): both >2 interproximal sites with CAL >6
mm and >1 interproximal site with PPD >5mm.
Moderate PD (M-PD): either >2 interproximal sites with(2)
CAL >4mm or >2 interproximal site with PPD >5mm.
Mild/none PD (N-PD): neither S-PD nor M-PD.(3)Exclusion criteria included: (A) fewer than 20 teeth in the
oral cavity, (b) need for antibiotic prophylaxis for more than
12hours prior to dental care as per the current American
Dental Association guidelines or use of an antibiotic in the
14 days prior to the study visit, (c) use of an antimicrobial
mouth rinse (0.12% chlorhexidine gluconate) 30 days prior to
the study visit, (d) use of teeth whitening in the 30 days prior
to the study visit, and (e) treatment of periodontal disease in
the 30 days prior to the study visit. HIV+ patients were
stratiﬁed by PD severity, whereas HIV– patients were only
stratiﬁed at the analysis stage due to the limited number of
controls available.2.2. Sample collection
Each participant had data abstracted from the medical record at
the time of enrolment which included demographics, date of HIV
diagnosis, opportunistic infections, laboratory values including
CD4 counts and HIV viral load levels, serologic status, major
clinical events including hospitalizations and surgeries, antire-
troviral history including adverse events to medications and other
co-morbidities, lipids, hemoglobin A1C, HIV-associated con-
ditions (infections, neoplasms, etc), other medical conditions
(diabetes, hyperlipidemia), and recent antimicrobial use. In
addition, whole blood was obtained from half of the participant
for immune activation analysis.
Saliva, cheek mucosa, and teeth specimens were obtained
from all participants and stored at –80°C. DNA was extracted
within a week and stored at –20°C prior to 16 seconds gene
ampliﬁcation. A curette was used to obtain dental plaque
samples from whole teeth, 1 posterior molar, and 1 anterior
incisor, in all participants. In participants with PD, samples
were taken from the deepest periodontal pocket of teeth that
was representative of the participant PD severity. Finally, 2
cheek samples were obtained from each participant. One
sample was obtained from the right cheek, and 1 sample was
obtained from the left cheek.
Participants were also administered a semistructured ques-
tionnaire which assessed demographic data, HIV serostatus,
antiretroviral use, oral health behaviors (brushing, ﬂossing),
tobacco/illicit drug/alcohol use, diet, use of antimicrobial
mouth rinses, dental prosthetic devices or teeth whitening,
prior oral/dental history, and utilization of dental care
services (number of visits). A dental exam was performed on
each participant to assess the missing, decayed, ﬁlled (MDF)
index, CAL and PPD measurements and to identify other
oral cavity conditions or diseases. Finally, a measure of
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measurements.2.3. DNA extraction, 16 s rRNA gene ampliﬁcation, and
sequencing
GenomicDNA from all samples was extracted utilizing theMoBio
PowerSoil DNA Isolation Kit (Cat # 12888–50) and quantiﬁed via
Quant-iT PicoGreen dsDNA Assay (Cat # P11496). The 16s V4
region was ampliﬁed through 30 cycles PCR with an F515 locus-
speciﬁc primer (50-TCGTCGGCAGCGTCAGATGTGTATAA-
GAGACAG-30) and an 806R-locus speciﬁc primer (50-GTCTC
GTGGGCTCGGAGATGTGTATAAGAGACAG-30) both with
compatible overhang regions for index attachment.[22] PCR
cleanup was performed using Agencourt AmpureXP magnetic
beads (Cat # A63880). V4 fragments for all samples were indexed
utilizing a second PCR reaction with Illumina Nextera Index XT
Kit (Cat # FC-121–1012) and index-adhering primers (1.1: 50-
AATGATACGGCGACCACCGAGAT-30; 2.1: 50-CAAGCA-
GAAGACGGCATACGA-30). Indexed fragments were puriﬁed
with Ampure XP beads, quantiﬁed with dsDNA Picogreen, and
pooled with respect to achieving equal molecular concentrations
for all samples in the ﬁnal library. About 250 paired-end
sequencing was performed on the MiSeq platform using an
IlluminaMiSeqVersion 2 500-cycle Kit (Cat #MS-102–2003) at a
loading concentration of 10 picomolar. An Illumina PhiX control
(Cat # FC-110–3001) was utilized in all MiSeq runs as
recommended in the MiSeq System User Guide for metagenomic
samples.2.4. Data analysis
Sequence data were quality ﬁltered with trimmomatic.[23] Eight
out of 250 (3%) samples (that were represented by less than 1000
sequence counts) were discarded. Mothur phylotype pipeline[24]
and SILVADB[25] /GreenGenes[26] databases were used to classify
sequences at the genus level. Alpha diversity and richness multiple
group comparisons were performed using rank based Mann–
Whitney or Kruskal–Wallis test combined with post-hoc
Nemenyi test implemented in PMCMR R[27] packages. For
taxonomical analysis, R/Bioconductor (Vegan,[28] PhyloSeq,[29]
and DESeq2)[30] software packages were used. Richness and
diversity were estimated using Chao1 and Shannon estimators
respectively as implemented in the Vegan package. Principal
Coordinates Analysis (PCoA) and weighted Unifrac distances
were used for unconstrained ordination on genus proportions.
Adonis was used to assess overall microbiome structure differ-
ences between deﬁned groups. A negative binomial ﬁt and Wald
test were run on every genus to assess differential abundance. P-
values were adjusted using the Benjamini–Hochberg correc-
tion.[31]
To predict the functional composition of the oral microbiome
from 16S data, we used PICRUSt.[32] First, the phylotype table
obtained by Mothur/GreenGenesDB was normalized by dividing
the abundance of each organism by its predicted 16S copy
number (script normalize_by_copy_number.py). To infer the
gene content (script predict_metagenomes.py), the normalized
phylotype abundances were multiplied by the respective set of
gene abundances (represented by KEGG identiﬁers) estimated for
each taxon. The gene content table obtained was used to analyze
the metabolic pathways represented at different KEGG level
categories structured in 3 hierarchical levels, usingHUMAnN.[33]
Finally, we identiﬁed putative biologically relevant pathways that3characterized the different sites, HIV status and PD states by
applying the LEfSe algorithm.[34]2.5. Polychromatic ﬂow cytometry
Flow cytometry and Boolean analysis were performed as
previously described[35,36] with a few modiﬁcations. Brieﬂy, 2
million peripheral blood mononuclear cells were re-suspended in
100mL of RPMI plus 10% fetal bovine serum (FBS) in a 5 mL
polypropylene tube. Cells were washed once with cold phosphate-
buffered saline (PBS) containing 2% FBS, surface stained at room
temperature for 30 minutes with antibodies speciﬁc to human
CD4, CD3, CD8, HLA-DR, and CD38 each conjugated to a
different ﬂuorophore. Cells were ﬁxed with cytoﬁx/cytoperm (BD
Pharmingen) and permeabilized with 1X permwash (BD Phar-
mingen). Cells were then incubated with antihuman Ki-67
antibody conjugated to a different ﬂuorochrome for 30 minutes
at 4°C.Cellswerewashed twicewith 1XPermwash, oncewith 2%
Fetal bovine serum(FBS) in phosphate buffered saline (PBS and re-
suspended in1%formalin in PBS.Cellswere acquired on theLSRII
(BD Immunocytometry systems) and analyzed using the FlowJo
software (Treestar, Inc., San Carlos, CA). Lymphocytes were
identiﬁed based on their scatter pattern, and CD3+, CD8-, CD4+
cells were considered as CD4 T cells, whereas CD3+, CD8+, CD4-
cells were considered asCD8T cells. CD38+,HLA-DR+orKi-67+
T cells were further deﬁned on total CD4 or CD8 T cells. Using the
CD38, Ki-67 and HLA-DR gates, a Boolean analysis was
performed to calculate the frequencies of the 7 different
combinations of subsets using the Flowjo software.
Correlationbetweeneverybacterial genus/PCoAaxisand immune
markers was performed through the ﬁt of a linear model for each
combination of immune marker. The Benjamini–Hochberg[31]
method was used for adjustment of multiple comparisons error.2.6. Ethics approval and consent to participate
The study was approved by the Emory University IRB under the
title “The Oral Metagenomics Study” (IRB00048095). All
participants provided informed consent.3. Results
This was a cross-sectional study including 50 participants.
Participant population characteristics and dental exam informa-
tion are shown in Table S1a, S1b, and S1c, http://links.lww.com/
MD/B524, respectively. Each participant contributed saliva,
tooth samples from 2 teeth, and 2 cheek mucosa samples. Of
these participants, 40 (80%) were HIV+. Only one of these
participants was ART naive. Only 8 of the total participants had
a detectable viral load, and 3 of these 8 had a viral load that was
less than 1000 copies permL. AlthoughHIV+ participants tended
to be homosexual older men compared to the HIV– participants,
the study population was well balanced with regard to PD status.
A total of 18 (36%), 16, and 16 (32%) of the participants
presented none/mild (N-PD), moderate (M-PD), and severe (S-
PD) PD, respectively. There were no signiﬁcant differences in the
salivary ﬂow rate, MDF (missing, decayed, ﬁlled teeth), or
salivary buffering capacity between N and M/S-PD participants.
242 of the samples provided more than 1000 sequences and were
used for downstream analyses. Of these, 94/100, 49/50, and 99/
100 were cheek, saliva, and teeth samples, respectively. A total of
148/408 (36.3%) different bacterial genera provided more than
100 counts and were kept for further analyses.
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When all sample sites were analyzed together, bacterial diversity
but not richness was consistently higher in tooth samples than in
both cheek and saliva samples through all PD stages and in both
HIV-positive and -negative participants (P<0.001 for all
comparisons, Fig. 1 and Fig. S1, http://links.lww.com/MD/
B525). Importantly, greater similarity was found in the same
participant teeth and cheek samples (Fig. S6, http://links.lww.
com/MD/B525) than between participants. Alpha diversity
measures regarding HIV infection were less consistent. HIV–
samples showed higher richness measures only in the M-PD
group (P<0.05), whereas this tendency was reversed in diversity
for the S-PD group (P<0.01). Additionally, S-PD was associatedFigure 1. Richness (observed species, Chao1 indices) and diversity (Shannon an
infection status by sampling site (B), and by PD and HIV infection status (C). HIV
4with higher richness and diversity measures, but only in cheek
samples.
PCoA ordination analyses showed a clear differentiation of
microbial structure among body sites sampled (adonis test P
value=0.001, R2=0.20, Fig. 2), whereas HIV status and PD
severity showed a statistically signiﬁcant but marginal contribu-
tion to microbial structure differentiation (HIV: adonis P value=
0.008, R2=0.01, PD: adonis P value=0.092, R2=0.01, Fig. S2,
http://links.lww.com/MD/B525), which was of similar magni-
tude to that of ethnicity (EthnicGroup adonis P value= <0.005,
R2=0.03) and sexual behaviour (SexBeh, adonis P value=
<0.05, R2=0.02). According to stratiﬁed analysis these factors
lost statistical signiﬁcance on saliva, but not for cheek and teethd Simpson indices) for different sampling sites by HIV infection status (A), HIV
= human immunodeﬁciency virus, PD = periodontal disease.
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Figure 2. PCoA ordination analysis. Axes 1 and 2 capture 58% of the variance
observed in the microbiome structure of all oral samples. According to
PERMANOVA analysis, sampling site explained 20% of the oral microbiome
structure (adonis test P value=0.001, R2=0.20). 10%was evenly explained by
other factors such as HIV infection (adonis test P value=0.001, R2=0.01),
ethnicity (adonis test P value=0.001, R2=0.03), sexual behaviour (adonis test
P value=0.006, R2=0.02) and periodontal disease severity (adonis test P
value=0.003, R2=0.02). HIV = human immunodeﬁciency virus, PCoA =
principal coordinates analysis.
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R2=0.05) and soda drink (adonis P value=<0.05, R2=0.06)
consumption became statistically relevant. Ethnicity had the
largest effect on teeth (adonis P value<=0.01, R2=0.07) and
cheek (adonis P value<=0.001, R2=0.17) samples. Important-
ly, PD effects on oral microbiome were only signiﬁcant for cheek
(adonis P value<=0.01, R2=0.06) but not for teeth or saliva
samples, whereas HIV infection exerted a similar effect on cheek
(adonis P value=0.05, R2=0.02) and teeth samples (adonis P
value<0.01, R2=0.03) but had no signiﬁcant impact in saliva
samples.
Firmicuteswas the most abundant phylum in all sampling sites
followed by Actinobacteria, Bacteroidetes, Fusobacteria, and
Proteobacteria, whose relative abundance order changed
depending on sampling site (Fig. S3, http://links.lww.com/MD/
B525). Differences linked to HIV infection affected the
Proteobacteria phylum, which was overabundant in HIV+ cheek
(log 2 Fold-Change (log 2 FC)):1.08, Padj<0.0051) and teeth
samples (log2FC:1.23, Padj<0.005),(Table S2, http://links.lww.
com/MD/B524) although there was no correlation of Proteobac-
teria abundance with viral load (VL) or CD4+ counts within the
HIV-positive group (data not shown). Changes in phylum
abundance with PD severity were more frequent. Synergistetes
and Spirochaetae, both low abundant phyla, were consistently
found to be more abundant in teeth, cheek, and saliva samples
from the S-PD group versus N-PD, whereas Proteobacteria and5Firmicutes phyla had a 2-fold reduction in cheek and saliva, but
not in teeth S-PD affected samples.
HIV infection status was also associated with relative
abundance changes of different bacterial genera. In particular,
Neisseria and genera of the unclassiﬁedNeisseriaceae family were
4-fold more abundant in samples from HIV+ participants (log 2
FC=1.84, Padj<0.001, Table 1 and Fig. 3). Interestingly, this
change in abundance was consistent through the different
anatomical sites, although with different levels of signiﬁcance
as well as in the age and sexual behavior adjusted model
(Table S5, http://links.lww.com/MD/B524). Importantly, the
Neisseria genus was also more abundant in samples from HIV+
participants through varying severity of PD, with similar fold-
change values (log 2 FC) with respect to HIV– samples (see
Table S3 & S4, http://links.lww.com/MD/B524). Interestingly,
Aggregatibacter genus abundance was higher in HIV+ N-PD
samples (log 2 FC=2.02, Padj<0.005), but not in more advanced
PD stages. Furthermore, 3 different genera (Abiotrophia, Rothia
and unclassiﬁed Pasteurellaceae) that were uniquely enriched in
cheek HIV+ N-PD samples, were otherwise overabundant in M-
PD and S-PD teeth, but not saliva samples, suggesting a tissue
shift of these genera along PD severity (Table S4, http://links.lww.
com/MD/B524). Other genera were found to be differentially
abundant in either HIV+ teeth, saliva or cheek samples, but not
generally, in such away that HIV associated changed inmicrobial
genera were found to be localized to single site/PD severity
combinations.
Of the bacterial genera that are traditionally linked to PD[6]
only Treponema genus was found to be overabundant in S-PD
when compared to N-PD, when HIV infection was not
considered, in both cheek (log 2 FC=1.83, Padj<0.005) and
saliva (log 2 FC=2.6, Padj<0.001) samples, albeit in very low
abundance (Table 1). These were accompanied by other genera,
underlining the complex multicomponent nature of microbiome
disbyosis with PD. Cheek samples showed the greatest number of
differentially abundant bacterial genera along PD severity. Severe
PD was associated, with a 2-fold reduction in highly abundant
Streptococcus, Veillonella genera, and unclassiﬁed Pasteurella-
ceae family, whereas the 2 latter also showed similar under-
abundance in saliva samples. Interestingly, the Neisseria genus
was not found to be over- or under-represented in different PD
stages.3.2. Immune activation
Immune activation markers were available for a subset of 24
participants (8 N-PD, 8M-PD, and 8 S-PD), whereas CD4 counts
were only available for the subset of HIV-positive participants.
Despite the fact most HIV-positive participants were receiving
ART (see Table S1c, http://links.lww.com/MD/B524), there was
a strong association between HIV infection and immune
activation, proliferation, and translocation markers (Fig. 4).
This association was also found for CD4+ T cell counts and PD
severity, showing a higher CD4+ count in N-PD participants,
indicating a deterioration of the immune system both with
moderate or severe PD. Interestingly, immune markers for
proliferation were found to be higher both for the CD8 and CD4
T-cell subset in moderate M-PD than in both N-PD and S-PD,
whereas markers for cell activation were not signiﬁcantly
differently across PD severity.
Immune activation markers were correlated with both genus
abundance and projection of each of the samples against each of
the ﬁrst 3 ordination PCoA axes from the analysis segregated by
Table 1
Genus level signiﬁcant changes in abundance associated with HIV infection (HIV+) stratiﬁed by severity of PD.
HIV+ vs HIV– Sev/ModPD vs mild/NonePD
Global Base mean Log 2 FC Padj Log 2 FC Padj
Neisseria 222.6 1.84 <0.001 N/S N/S
Uncl. Neisseriaceae 131.8 1.50 <0.001 N/S N/S
Uncl. Veillonellaceae 121.0 –1.21 <0.005 –0.68 <0.05
Leptotrichia 687.3 –0.93 <0.01 N/S N/S
Centipeda 199.8 –1.06 <0.05 N/S N/S
Kingella 101.9 0.98 <0.1 N/S N/S
Selenomonas 254.8 –0.87 <0.1 N/S N/S
Rothia 1112.0 0.68 <0.1 N/S N/S
Granulicatella 190.9 N/S N/S –0.92 <0.001
Streptococcus 4314.7 N/S N/S –0.83 <0.001
Gemella 307.7 N/S N/S –0.84 <0.005
Veillonella 4169.0 N/S N/S –0.71 <0.01
Capnocytophaga 173.7 N/S N/S –0.65 <0.05
Corynebacterium 577.7 N/S N/S –0.71 <0.1
Neisseria 214.7 2.38 <0.001 N/S N/S
Uncl. Neisseriaceae 134.3 1.92 <0.001 N/S N/S
Uncl. Pasteurellaceae 518.2 1.45 <0.05 N/S N/S
Leptotrichia 945.4 –1.20 <0.05 N/S N/S
Centipeda 396.9 –1.30 <0.1 N/S N/S
Granulicatella 101.5 N/S N/S –1.01 <0.1
Capnocytophaga 317.3 N/S N/S –0.93 <0.1
Neisseria 228.1 2.25 <0.001 N/S N/S
Prevotella 453.8 –0.82 <0.05 N/S N/S
Streptococcus 7321.3 N/S N/S –1.31 <0.001
Rothia 975.8 N/S N/S –1.19 <0.005
Veillonella 3593.8 N/S N/S –0.94 <0.01
Uncl. Pasteurellaceae 1390.6 N/S N/S –1.08 <0.05
Haemophilus 161.7 N/S N/S –1.82 <0.05
Gemella 597.4 N/S N/S –1.13 <0.05
Corynebacterium 125.1 N/S N/S 1.19 <0.05
Selenomonas 101.0 N/S N/S 1.06 <0.05
Capnocytophagaa 70.3 N/S N/S 0.92 <0.05
Treponemaa 21.7 N/S N/S 1.84 <0.001
Uncl. Neisseriaceae 285.4 1.81 <0.1 N/S N/S
Veillonella 8770.3 N/S N/S –0.86 <0.1
Uncl. Pasteurellaceae 849.6 N/S N/S –1.16 <0.1
Treponemaa 29.3 N/S N/S 2.59 <0.001
Leptotrichia 775.0 N/S N/S –1.10 <0.1
Only differences with Padj <0.1 and base mean >100 are shown.
HIV = human immunodeﬁciency virus, log2FC (A vs B) = log2 (A/B), N/S = not signiﬁcant, PD = periodontal disease.
Noguera-Julian et al. Medicine (2017) 96:12 Medicinesampling. A strong and signiﬁcant correlationwas found between
HLA-DR+/Ki67+/CD38- cell subset and increasing abundance of
Streptococcus genus (R2=0.61, Padj (FDR)<0.001, Fig. S4,
http://links.lww.com/MD/B525), only in saliva samples. In
addition, none of the immune activation markers nor CD4+ T
cell counts showed a signiﬁcant correlation with any of the PCoA
axes (data not shown) in any sampling site type. Interestingly, a 4-
fold depletion of the Streptococcus genus was associated with
HIV+ status in cheek S-PD samples. Although this depletion in
cheek samples was not accompanied by signiﬁcant changes in
teeth or saliva S-PD samples, there was a general and signiﬁcant
trend towards Streptococcus depletion globally in S-PD HIV+
participants, whereas this genus was enriched in N-PD HIV+
participants.3.3. Functional analysis
Functional analysis using the PiCRUSt inferred gene content also
revealed major differences among sampling sites (Fig. S5, http://6links.lww.com/MD/B525). Teeth samples were enriched in cell
motility pathways including chemotaxis and ﬂagellar assembly,
probably reﬂecting tooth bioﬁlm formation. Genes within
carbohydrate, vitamins, and lipid metabolism pathways were
enriched in cheek samples. No signiﬁcant differences in the
functional gene content could be consistently linked to HIV
infection in any PD severity or anatomic site. In combination with
taxonomical analysis and the lack of correlation between HIV-
linked bacterial genera and inﬂammation, this underlines the
nonpathogenic character of the increased abundance ofNeisseria
genus and suggests the pathobiont nature of this genus in the
context of HIV-associated PD.[37]4. Discussion
This study adds important information to the paucity of
publications examining the effect of HIV status on the human
oral microbiome. As reported in other studies, major differences
in microbiome structure and composition were associated with
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Figure 3. Classiﬁed differential abundant genera between HIV+ and HIV– samples. Log 2 Fold Change is plotted on the X-axis. Phyla is indicated using color codes.
Point size indicates the mean count for a particular genus on the whole sample set. HIV = human immunodeﬁciency virus.
Noguera-Julian et al. Medicine (2017) 96:12 www.md-journal.comthe anatomic sampling site of patients, underscoring the great
diversity and biogeography within the oral microbiome.
Globally, PD severity was associated with a broader change
within the oral microbiome than HIV infection. PD affected a
high number of bacterial genera, and these changes were of
greater magnitude due to the mean abundance of affected genera
and showed speciﬁcity for the sampling site. For instance,
Veillonella and Streptococcus, both dominant genera in cheek
mucosa and saliva, had a 2-fold reduction, thus contributing to
alpha-diversity increases detected in these 2 sampling sites with
PD severity. In addition, low-abundant members of the
Treponema genus belonging to the PD-associated red complex
were also enriched in severe PD samples. Conversely, differences
in Tannerella and Porphyromonas genera along PD were not
observed in this dataset. In our study, these genera were found at
very low abundances (0.2% and 2.3%, mean abundances,
respectively) in teeth and not differentially abundant along PD
severity. Interestingly, Hong et al described 2 types of microbial
communities in a PD-affected general population. Only one of
them was enriched in Tannerella and Porphyromonas and
associated to PD severity.[38] Our results may indicate that HIV
infectionmay result in a bias in the dysbiotic pathway toward PD.
HIV infection solely affected a few low-abundance bacterial
genera, including Neisseria, which was 4-fold enriched in 3
independent oral sampling sites. The Neisseria genus has been
previously found to be depleted in the subgingival plaque of
smokers,[39] whereas other sampling sites have not been explored
to this respect. In our dataset, smoking also had a depleting effect
in the 3 different sampling sites. Although it cannot be absolutely
ruled out that other confounding factors may be affecting our
results, our study design was well-balanced and no signiﬁcant
interaction between smoker status and HIV infection was
detected. Furthermore, the Neisseria genus enrichment was still
associated with HIV infection in the nonsmoker subset (log 27FC=1.48, Padj<0.05), although statistical signiﬁcance was
marginally lost for the smoker smaller subset (log 2 FC=1.1,
Padj=0.15). Also, sexual behavior has been linked to changes in
the gut microbiome.[40] Although, in our dataset, HIV infection
was enriched in men who had sex with men, this factor alone had
a small effect on the oral microbiome structure (adonis test R2=
0.02, Pr (>F)=0.032) and the age and sexual behavior adjusted
model provided a similar picture in bacterial differential
abundance than the unadjusted one. Several species that belong
to the Neisseria genus such as N bacilliformis and N elongata,
considered as nonpathogenic[41,42] or related to PD,[16] have been
associated with respiratory and oral cavity infections.[43] The role
of oral Neisseria genus in HIV infection has attracted limited
attention; the few published studies using distinct sampling
techniques had contradictory results. Recently, N. elongata was
found to be enriched in the salivary microbiome of AIDS
patients,[18] but minor nonsigniﬁcant changes in this genera were
found between HIV-positive participants before and after
commencing ART and when compared to seronegative partic-
ipants in another study.[19] In addition, colonization of N
ﬂavescens was lower in the lingual microbiome of HIV-positive
patients receiving ART than in HIV-negative controls.
Of note, no relation between Neisseria and Neisseriaceae
family abundance and immune activation markers could be
detected. This could be explained both by the commensal
nonpathogenic nature of Neisseria genus and by a potential
competitive advantage in HIV+ participants that affected all
sampling sites, even under ART.5. Conclusions
PD and HIV infection were associated with signiﬁcant micro-
biome changes within anatomic sampling sites. Three major
ﬁndings were uncovered in this analysis: (1) Neisseria spp.
Figure 4. Immune activation, proliferation, and bacterial translocation markers according to the HIV infection and the PD stage. Y-axis values for immune markers
represent proportion of CD4/CD8 population resulting of the gate strategy described in the plot title. CD4+ T-cell counts were unavailable for HIV– subjects. HIV =
human immunodeﬁciency virus, PD = periodontal disease.
Noguera-Julian et al. Medicine (2017) 96:12 Medicineappeared to be enriched in HIV-positive participants compared
to HIV-negative participants across all sampling sites, (2) among
HIV+ participants Abiotrophia, Rothia, and unclassiﬁed Pas-
teurellaceae were enriched in M-PD and S-PD compared to N-
PD, and (3) Treponema spp. were enriched in S-PD compared to
N-PD for all participants. PD moderate severity was associated
with higher CD4 and CD8 proliferation; however, associations
with other inﬂammatory parameters relevant for HIV pathoge-
nicity were not found.
Although Neisseria genus was found to be enriched in the oral
microbiome of HIV-positive participants, it showed no linkage to8either inﬂammation, immune parameters, or functional gene
content. Relative abundance increase was consistently found in
teeth, cheek mucosa, and saliva samples and in samples from
participants with mild or no PD, but also moderate and severe
PD. Changes in other bacterial genera related to HIV infection
were scarce and had a very limited effect on bacterial diversity.Acknowledgments
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